Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2011 (2011), Article ID 164197, 7 pages
http://dx.doi.org/10.1155/2011/164197
Research Article

AP-1 as a Regulator of MMP-13 in the Stromal Cell of Giant Cell Tumor of Bone

1Department of Surgery, McMaster University, Hamilton, ON, Canada L8S 4L8
2Department of Surgery, Juravinski Cancer Centre, Hamilton Health Sciences, Hamilton, ON, Canada L8V 5C2
3Department of Orthopaedic, McGill University Health Centre, Montreal General Hospital, QC, Canada H3G 1A4
4Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada L8S 4L8

Received 26 August 2010; Revised 2 December 2010; Accepted 4 January 2011

Academic Editor: Martin Berchtold

Copyright © 2011 Isabella W. Y. Mak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Cohen Jr., “The new bone biology: pathologic, molecular, and clinical correlates,” American Journal of Medical Genetics A, vol. 140, no. 23, pp. 2646–2706, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. J. Malemud, “Matrix metalloproteinases: role in skeletal development and growth plate disorders,” Frontiers in Bioscience, vol. 11, no. 2, pp. 1702–1715, 2006. View at Google Scholar · View at Scopus
  3. C. J. Malemud, “Matrix metalloproteinases (MMPs) in health and disease: an overview,” Frontiers in Bioscience, vol. 11, no. 2, pp. 1696–1701, 2006. View at Google Scholar · View at Scopus
  4. M. Ghert, N. Simunovic, R. W. Cowan, N. Colterjohn, and G. Singh, “Properties of the stromal cell in giant cell tumor of bone,” Clinical Orthopaedics and Related Research, no. 459, pp. 8–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. W. Cowan, I. W. Y. Mak, N. Colterjohn, G. Singh, and M. Ghert, “Collagenase expression and activity in the stromal cells from giant cell tumour of bone,” Bone, vol. 44, no. 5, pp. 865–871, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. I. W. Y. Mak, E. P. Seidlitz, R. W. Cowan et al., “Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone,” Human Pathology, vol. 41, pp. 1320–1329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. I. W. Y. Mak, R. W. Cowan, S. Popovic, N. Colterjohn, G. Singh, and M. Ghert, “Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of bone,” Bone, vol. 45, no. 2, pp. 377–386, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Pendas, M. Balbin, E. Llano, M. G. Jimenez, and C. Lopez-Otin, “Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13),” Genomics, vol. 40, no. 2, pp. 222–233, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Takaishi, T. Kimura, S. Dalal, Y. Okada, and J. D'Armiento, “Joint diseases and matrix metalloproteinases: a role for MMP-13,” Current Pharmaceutical Biotechnology, vol. 9, no. 1, pp. 47–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Ala-Aho and V. M. Kahari, “Collagenases in cancer,” Biochimie, vol. 87, no. 3-4, pp. 273–286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. T. Peterson, “The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors,” Cardiovascular Research, vol. 69, no. 3, pp. 677–687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. P. Hudson, P. W. Armstrong, W. Ruzyllo et al., “Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial,” Journal of the American College of Cardiology, vol. 48, no. 1, pp. 15–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. C. M. Overall and O. Kleifeld, “Towards third generation matrix metalloproteinase inhibitors for cancer therapy,” British Journal of Cancer, vol. 94, no. 7, pp. 941–946, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Selvamurugan, S. C. Jefcoat, S. Kwok, R. Kowalewski, J. A. Tamasi, and N. C. Partridge, “Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo,” Journal of Cellular Biochemistry, vol. 99, no. 2, pp. 545–557, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Hess, D. Porte, C. Munz, and P. Angel, “AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element,” Journal of Biological Chemistry, vol. 276, no. 23, pp. 20029–20038, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. B. W. Ozanne, H. J. Spence, L. C. McGarry, and R. F. Hennigan, “Transcription factors control invasion: AP-1 the first among equals,” Oncogene, vol. 26, no. 1, pp. 1–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Shaulian and M. Karin, “AP-1 in cell proliferation and survival,” Oncogene, vol. 20, no. 19, pp. 2390–2400, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. J. B. Lian, G. S. Stein, A. Javed et al., “Networks and hubs for the transcriptional control of osteoblastogenesis,” Reviews in Endocrine and Metabolic Disorders, vol. 7, no. 1-2, pp. 1–16, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Iwamoto, J. Kitagaki, Y. Tamamura et al., “Runx2 expression and action in chondrocytes are regulated by retinoid signaling and parathyroid hormone-related peptide (PTHrP),” Osteoarthritis and Cartilage, vol. 11, no. 1, pp. 6–15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Ueta, M. Iwamoto, N. Kanatani et al., “Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes,” Journal of Cell Biology, vol. 153, no. 1, pp. 87–99, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Vortkamp, K. Lee, B. Lanske, G. V. Segre, H. M. Kronenberg, and C. J. Tabin, “Regulation of rate of cartilage differentiation by Indian Hedgehog and PTH-related protein,” Science, vol. 273, no. 5275, pp. 613–622, 1996. View at Google Scholar · View at Scopus